Revenue: The sum of all revenue fields included for a company's operating activities.
Gilead Sciences, Inc. (GILD) had Revenue of $27.12B for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
Revenue |
$27.12B |
$5.67B |
|
$6.50B |
|
$20.62B |
|
$19.51B |
|
$7.61B |
|
$-746.00M |
|
$6.86B |
|
$6.86B |
|
$5.61B |
|
$5.61B |
|
$5.61B |
|
$5.61B |
|
$7.61B |
|
$10.30B |
|
1.25B |
|
1.26B |
|
$4.54 |
|
$4.50 |
|
Balance Sheet Financials | |
$16.09B |
|
$5.32B |
|
$46.04B |
|
$62.12B |
|
$11.28B |
|
$24.47B |
|
$28.10B |
|
$39.38B |
|
$22.75B |
|
$-12.02B |
|
$22.75B |
|
1.25B |
|
Cash Flow Statement Financials | |
$8.01B |
|
$-2.27B |
|
$-5.12B |
|
$5.41B |
|
$6.08B |
|
$673.00M |
|
$766.00M |
|
$-3.81B |
|
-- |
|
Fundamental Metrics & Ratios | |
1.43 |
|
-- |
|
-- |
|
0.52 |
|
1.15 |
|
76.04% |
|
28.05% |
|
28.05% |
|
37.98% |
|
25.30% |
|
20.89% |
|
$7.42B |
|
-- |
|
-- |
|
-- |
|
0.44 |
|
3.64 |
|
5.82 |
|
62.73 |
|
24.67% |
|
-46.69% |
|
9.03% |
|
11.89% |
|
$18.26 |
|
$5.90 |
|
$6.36 |